Cambridge Investment Research Advisors
CC icon

Cambridge Investment Research Advisors’s Chemours CC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,477
Closed -$142K – 3640
2025
Q1 		$142K Buy
10,477
+200
+2% +$3.32K ﹤0.01% 3284
2024
Q4 		$174K Sell
10,277
-1,100
-10% -$21.4K ﹤0.01% 3223
2024
Q3 		$231K Sell
11,377
-2,152
-16% -$44K ﹤0.01% 3029
2024
Q2 		$305K Buy
13,529
+62
+0.5% +$1.62K ﹤0.01% 2692
2024
Q1 		$354K Sell
13,467
-643
-5% -$18.3K ﹤0.01% 2572
2023
Q4 		$445K Sell
14,110
-52
-0.4% -$1.41K ﹤0.01% 2282
2023
Q3 		$397K Buy
14,162
+386
+3% +$13.3K ﹤0.01% 2275
2023
Q2 		$508K Sell
13,776
-1,622
-11% -$49.5K ﹤0.01% 2124
2023
Q1 		$461K Sell
15,398
-347
-2% -$11.4K ﹤0.01% 2150
2022
Q4 		$482K Sell
15,745
-667
-4% -$20K ﹤0.01% 2041
2022
Q3 		$405K Buy
16,412
+605
+4% +$20K ﹤0.01% 2106
2022
Q2 		$506K Sell
15,807
-2,161
-12% -$79.5K ﹤0.01% 1952
2022
Q1 		$566K Sell
17,968
-459
-2% -$14.4K ﹤0.01% 2004
2021
Q4 		$618K Buy
18,427
+4,939
+37% +$154K ﹤0.01% 1941
2021
Q3 		$392K Buy
13,488
+465
+4% +$15.1K ﹤0.01% 2235
2021
Q2 		$453K Buy
13,023
+2,413
+23% +$79.9K ﹤0.01% 2134
2021
Q1 		$296K Buy
10,610
+838
+9% +$22.3K ﹤0.01% 2294
2020
Q4 		$242K Sell
9,772
-1,829
-16% -$43.5K ﹤0.01% 2315
2020
Q3 		$243K Buy
11,601
+1,282
+12% +$24.7K ﹤0.01% 2091
2020
Q2 		$158K Buy
+10,319
New +$130K ﹤0.01% 2232
2020
Q1 		– Sell
-18,416
Closed -$333K – 2287
2019
Q4 		$333K Buy
+18,416
New +$306K ﹤0.01% 1845
2019
Q3 		– Sell
-13,098
Closed -$314K – 2348
2019
Q2 		$314K Sell
13,098
-6,210
-32% -$183K ﹤0.01% 1719
2019
Q1 		$717K Buy
19,308
+8,446
+78% +$307K 0.01% 1250
2018
Q4 		$307K Sell
10,862
-2,566
-19% -$81.2K ﹤0.01% 1647
2018
Q3 		$530K Sell
13,428
-1,975
-13% -$86.4K 0.01% 1409
2018
Q2 		$683K Sell
15,403
-137
-0.9% -$6.82K 0.01% 1224
2018
Q1 		$757K Buy
15,540
+2,101
+16% +$105K 0.01% 1097
2017
Q4 		$673K Buy
13,439
+1,479
+12% +$77.5K 0.01% 1136
2017
Q3 		$605K Buy
11,960
+1,664
+16% +$78.5K 0.01% 1138
2017
Q2 		$390K Buy
10,296
+2,738
+36% +$108K 0.01% 1359
2017
Q1 		$291K Buy
+7,558
New +$227K 0.01% 1404
2016
Q3 		– Sell
-22,256
Closed -$183K – 1749
2016
Q2 		$183K Sell
22,256
-935
-4% -$8.33K ﹤0.01% 1394
2016
Q1 		$162K Buy
23,191
+3,903
+20% +$19.6K ﹤0.01% 1439
2015
Q4 		$103K Sell
19,288
-4,428
-19% -$28.3K ﹤0.01% 1483
2015
Q3 		$153K Buy
+23,716
New +$248K ﹤0.01% 1310

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cambridge Investment Research Advisors's CC Position: Q2 2025 in Review

Cambridge Investment Research Advisors sold out of Chemours (CC) in Q2 2025, closing a stake of 10,477 shares — an estimated $142K sold.

Cambridge Investment Research Advisors first reported a position in CC in Q3 2015 and held it in 35 quarters. The position peaked at $757K in Q1 2018. 434 funds tracked by Wall St. Rank hold CC as of Q2 2025.

  • Cambridge Investment Research Advisors reported no remaining Chemours position as of Q2 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,477 Chemours shares in Q2 2025, an estimated $142K.
  • Cambridge Investment Research Advisors first reported a position in Chemours in Q3 2015 and held it in 35 quarters.
  • Cambridge Investment Research Advisors's Chemours position peaked at $757K in Q1 2018.
  • 434 funds tracked by Wall St. Rank held Chemours as of Q2 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.